Top

Current Cardiology Reports

Published in:

01-08-2017 | Valvular Heart Disease (T Kiefer, Section Editor)

Mitral Valve Disease: a Comprehensive Review

Authors: Serge C. Harb, Brian P. Griffin

Published in: Current Cardiology Reports | Issue 8/2017

Abstract

Purpose of Review

This review aims to provide a comprehensive assessment of mitral valve disease, both mitral stenosis and mitral regurgitation, starting with an overview of the valve anatomy.

Recent Findings

The advent of three-dimensional imaging has allowed a better representation of the valve anatomy. Rheumatic disease is still the number one cause of mitral stenosis worldwide and percutaneous balloon mitral valvuloplasty remains the therapy of choice when indicated and in anatomically eligible patients. Mitral regurgitation (MR) is classified as primary (i.e., lesion in the mitral apparatus) or secondary (caused by left ventricular geometrical alterations). While surgery, preferably repair, is still the recommended therapy for severe primary MR, percutaneous approaches to repair and/or replace the mitral valve are being extensively investigated.

Summary

Mitral valve disease is common. A careful understanding of mitral valve anatomy and the disease processes that affect the valve are crucial for providing optimal patient care.

Van Mieghem NM, Piazza N, Anderson RH, Tzikas A, Nieman K, De Laat LE, et al. Anatomy of the mitral valvular complex and its implications for transcatheter interventions for mitral regurgitation. J Am Coll Cardiol. 2010;56(8):617–26. doi:10.1016/j.jacc.2010.04.030.CrossRefPubMed

Perloff JK, Roberts WC. The mitral apparatus. Functional anatomy of mitral regurgitation. Circulation. 1972;46(2):227–39.CrossRefPubMed

Anwar AM, Soliman OI, ten Cate FJ, Nemes A, McGhie JS, Krenning BJ, et al. True mitral annulus diameter is underestimated by two-dimensional echocardiography as evidenced by real-time three-dimensional echocardiography and magnetic resonance imaging. Int J Card Imaging. 2007;23(5):541–7. doi:10.1007/s10554-006-9181-9.CrossRef

Muresian H. The clinical anatomy of the mitral valve. Clin Anat. 2009;22(1):85–98. doi:10.1002/ca.20692.CrossRefPubMed

Ho SY. Anatomy of the mitral valve. Heart. 2002;88(Suppl 4):iv5–10.PubMedPubMedCentral

Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet. 2005;366(9480):155–68. doi:10.1016/S0140-6736(05)66874-2.CrossRef

Pressman GS, Agarwal A, Braitman LE, Muddassir SM. Mitral annular calcium causing mitral stenosis. Am J Cardiol. 2010;105(3):389–91. doi:10.1016/j.amjcard.2009.09.042.CrossRefPubMed

Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA. 2003;290(21):2831–7. doi:10.1001/jama.290.21.2831.CrossRefPubMed

Ruckman RN, Van Praagh R. Anatomic types of congenital mitral stenosis: report of 49 autopsy cases with consideration of diagnosis and surgical implications. Am J Cardiol. 1978;42(4):592–601.CrossRefPubMed

10.

Hugenholtz PG, Ryan TJ, Stein SW, Abelmann WH. The spectrum of pure mitral stenosis. Hemodynamic studies in relation to clinical disability. Am J Cardiol. 1962;10:773–84.CrossRefPubMed

11.

Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22(1):1–23; quiz 101-2. doi:10.1016/j.echo.2008.11.029.CrossRefPubMed

12.

•• Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014;63(22):e57–185. doi:10.1016/j.Jacc.2014.02.536. This report constitues the AHA/ACC recommendations for the management of patients with valvular heart disease.CrossRefPubMed

13.

•• Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. AHA/ACC focused update of the 2014 AHA/ACC guideline for the Management of Patients with Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2017, 2017; doi:10.1016/j.Jacc.2017.03.011. This report is the recent (2017) AHA/ACC focused update of the valvular guidelines.

14.

Schlosshan D, Aggarwal G, Mathur G, Allan R, Cranney G. Real-time 3D transesophageal echocardiography for the evaluation of rheumatic mitral stenosis. JACC Cardiovasc Imaging. 2011;4(6):580–8. doi:10.1016/j.jcmg.2010.12.009.CrossRefPubMed

15.

Gorlin R, Gorlin SG. Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. I. Am Heart J. 1951;41(1):1–29.CrossRefPubMed

16.

Rodriguez L, Thomas JD, Monterroso V, Weyman AE, Harrigan P, Mueller LN, et al. Validation of the proximal flow convergence method. Calculation of orifice area in patients with mitral stenosis. Circulation. 1993;88(3):1157–65.CrossRefPubMed

17.

Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J. 1988;60(4):299–308.CrossRefPubMedPubMedCentral

18.

Luxereau P, Dorent R, De Gevigney G, Bruneval P, Chomette G, Delahaye G. Aetiology of surgically treated mitral regurgitation. Eur Heart J. 1991;12(Suppl B):2–4.CrossRefPubMed

19.

Anyanwu AC, Adams DH. Etiologic classification of degenerative mitral valve disease: Barlow's disease and fibroelastic deficiency. Semin Thorac Cardiovasc Surg. 2007;19(2):90–6. doi:10.1053/j.semtcvs.2007.04.002.CrossRefPubMed

20.

Carpentier A. Cardiac valve surgery—the “French correction”. J Thorac Cardiovasc Surg. 1983;86(3):323–37.PubMed

21.

Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16(7):777–802. doi:10.1016/S0894-7317(03)00335-3.CrossRefPubMed

22.

Chen CG, Thomas JD, Anconina J, Harrigan P, Mueller L, Picard MH, et al. Impact of impinging wall jet on color Doppler quantification of mitral regurgitation. Circulation. 1991;84(2):712–20.CrossRefPubMed

23.

Marsan NA, Westenberg JJ, Ypenburg C, Delgado V, van Bommel RJ, Roes SD, et al. Quantification of functional mitral regurgitation by real-time 3D echocardiography: comparison with 3D velocity-encoded cardiac magnetic resonance. JACC Cardiovasc Imaging. 2009;2(11):1245–52. doi:10.1016/j.jcmg.2009.07.006.CrossRefPubMed

24.

Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19):2451–96. doi:10.1093/eurheartj/ehs109.CrossRefPubMed

25.

Maisano F, La Canna G, Colombo A, Alfieri O. The evolution from surgery to percutaneous mitral valve interventions: the role of the edge-to-edge technique. J Am Coll Cardiol. 2011;58(21):2174–82. doi:10.1016/j.jacc.2011.07.046.CrossRefPubMed

26.

De Backer O, Piazza N, Banai S, Lutter G, Maisano F, Herrmann HC, et al. Percutaneous transcatheter mitral valve replacement: an overview of devices in preclinical and early clinical evaluation. Circ Cardiovasc Interv. 2014;7(3):400–9. doi:10.1161/Circinterventions.114.001607.CrossRefPubMed

27.

• Smith PK, Puskas JD, Ascheim DD, Voisine P, Gelijns AC, Moskowitz AJ, et al. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2014;371(23):2178–88. doi:10.1056/NEJMoa1410490. This study, along with the study referenced below, showed that surgical treatment of ischemic mitral regurgitation did not provide a clinically meanigful benefit.CrossRef

28.

• Michler RE, Smith PK, Parides MK, Ailawadi G, Thourani V, Moskowitz AJ, et al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2016;374(20):1932–41. doi:10.1056/NEJMoa1602003. This study reports the 2-year outcomes of the surgical treatment of ischemic mitral regurgitation, similarly showing the lack of benefit.CrossRef

29.

• Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 2014;370(1):23–32. doi:10.1056/NEJMoa1312808. This study shows no significant difference between patients who underwent mitral-valve repair and those who underwent mitral-valve replacement.CrossRef

30.

Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Perrault LP, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374(4):344–53. doi:10.1056/NEJMoa1512913.CrossRefPubMed

31.

Alashi A, Mentias A, Patel K, Gillinov AM, Sabik JF, Popovic ZB, et al. Synergistic utility of brain natriuretic peptide and left ventricular global longitudinal strain in asymptomatic patients with significant primary mitral regurgitation and preserved systolic function undergoing mitral valve surgery. Circ Cardiovasc Imaging. 2016;9(7) doi:10.1161/CIRCIMAGING.115.004451.

32.

Mentias A, Naji P, Gillinov AM, Rodriguez LL, Reed G, Mihaljevic T, et al. Strain echocardiography and functional capacity in asymptomatic primary mitral regurgitation with preserved ejection fraction. J Am Coll Cardiol. 2016;68(18):1974–86. doi:10.1016/j.jacc.2016.08.030.CrossRefPubMed

33.

Mentias A, Naji P, Barr T, Gillinov AM, Rodriguez LL, Mihaljevic T, et al. Incremental prognostic utility of LV global longitudinal strain and functional capacity in asymptomatic patients with significant primary mitral regurgitation and preserved left ventricular ejection fraction undergoing rest-stress echocardiography. Circulation. 2015;132

34.

Mentias A, Patel K, Patel H, Gillinov AM, Sabik JF, Mihaljevic T, et al. Effect of pulmonary vascular pressures on long-term outcome in patients with primary mitral regurgitation. J Am Coll Cardiol. 2016;67(25):2952–61. doi:10.1016/j.jacc.2016.03.589.CrossRefPubMed

Title: Mitral Valve Disease: a Comprehensive Review
Authors: Serge C. Harb
Brian P. Griffin
Publication date: 01-08-2017
Publisher: Springer US
Published in: Current Cardiology Reports / Issue 8/2017
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-017-0883-5

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Mitral Valve Disease: a Comprehensive Review

Abstract

Purpose of Review

Recent Findings

Summary

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 8/2017

Adverse Remodeling and Reverse Remodeling After Myocardial Infarction

The Miracle Baby Grows Up: Hypoplastic Left Heart Syndrome in the Adult

Update on Neurocritical Care of Stroke

PCSK9 Inhibitors: Treating the Right Patients in Daily Practice

Novel Risk Stratification Assays for Acute Coronary Syndrome

Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page